GOLDMAN SACHS GROUP INC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 62 filers reported holding REPROS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$7,000
+75.0%
11,147
-3.4%
0.00%
Q3 2017$4,000
-33.3%
11,541
-11.9%
0.00%
Q2 2017$6,000
-62.5%
13,107
-3.8%
0.00%
Q1 2017$16,000
-33.3%
13,625
-24.9%
0.00%
Q4 2016$24,000
-25.0%
18,145
+18.7%
0.00%
Q3 2016$32,000
+28.0%
15,290
-2.1%
0.00%
Q2 2016$25,000
-54.5%
15,618
-72.6%
0.00%
Q1 2016$55,000
-73.4%
57,044
-66.7%
0.00%
Q4 2015$207,000
-86.2%
171,431
-15.3%
0.00%
Q3 2015$1,505,000
+71.4%
202,515
+64.9%
0.00%
Q2 2015$878,000
+83.3%
122,776
+120.0%
0.00%
Q1 2015$479,000
-86.1%
55,811
-83.8%
0.00%
-100.0%
Q4 2014$3,440,000
+262.5%
345,025
+259.9%
0.00%
Q3 2014$949,000
+6.0%
95,864
+85.2%
0.00%
Q2 2014$895,000
-43.7%
51,759
-42.3%
0.00%
-100.0%
Q1 2014$1,591,000
-13.9%
89,694
-11.1%
0.00%
Q4 2013$1,847,000
-92.4%
100,920
-88.9%
0.00%
-100.0%
Q3 2013$24,368,000
+5.0%
909,234
-27.7%
0.01%
-10.0%
Q2 2013$23,208,000
+145.4%
1,257,913
+109.4%
0.01%
+150.0%
Q4 2012$9,459,000
+10071.0%
600,597
+5784.2%
0.00%
Q2 2012$93,00010,2070.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$9,727,0002.05%
RTW INVESTMENTS, LP 229,364$1,970,0000.89%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 361,300$3,104,0000.85%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,826,0000.73%
SENZAR ASSET MANAGEMENT, LLC 244,006$2,096,0000.51%
GENERAL AMERICAN INVESTORS CO INC 508,375$4,367,0000.36%
CQS Cayman LP 700,000$6,013,0000.28%
Rotella Capital Management, Inc. 20,800$179,0000.15%
Baker Brothers Advisors 2,000,000$17,180,0000.14%
Gruss Capital Management LP 304,000$2,611,0000.11%
View complete list of REPROS THERAPEUTICS INC shareholders